Abinza Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 3 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 15.50 Cr
- Revenue Growth %
- Ebitda
- Net Worth
- Total Assets 55.99%
About Abinza Pharma
Abinza Pharma Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 September 2021 (Three years and four months 13 days old ). Its registered office is in Jammu, Jammu & Kashmir, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹15.50 Cr.
Sanjeev Goel and Vishav Jindal serve as directors at the Company.
Company Details
-
Location
Jammu, Jammu & Kashmir, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24233JK2021PTC012734
-
Company No.
012734
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Sep 2021
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Jammu
Industry
Who are the key members and board of directors at Abinza Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjeev Goel
|
Director | 24-Dec-2021 | Current |
|
Vishav Jindal
|
Director | 20-Sep-2021 | Current |
Financial Performance of Abinza Pharma.
Abinza Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Abinza Pharma?
Unlock access to Abinza Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Associated Biotech Private LimitedSanjeev Goel is a mutual person
-
Nuveda Research & Labs LlpSanjeev Goel is a mutual person
-
Ivcure Pharma Private Limited
Sanjeev Goel and Vishav Jindal are mutual person
-
Scorda Pharma Private Limited
Sanjeev Goel and Vishav Jindal are mutual person
-
Medvalue Private Limited
Sanjeev Goel is a mutual person
-
Associated Biopharma Private Limited
Sanjeev Goel is a mutual person
Charges (Loans)
₹15.50 Cr
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 15.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Jul 2023 | Hdfc Bank Limited | ₹15.50 Cr | Open |
How Many Employees Work at Abinza Pharma?
Abinza Pharma has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Abinza Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abinza Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
